Please login to the form below
virtual trials
This page shows the latest virtual trials news and features for those working in and with pharma, biotech and healthcare.
Key emerging trends in digital health
Enter ‘virtual’ clinical trials, that are lauded not only for patient-centricity but also for providing researchers with a wealth of patient data in real time. ... Although investigators in the industry have presented concerns that as research
Latest news
-
Entering the era of digital trials
Connected inhalers provide comparable oversight of adherence for inhaled medications. Going virtual Individually, these technologies and many others in development stand to improve distinct parts of clinical trials. ... These obstacles to fully virtual
-
Novartis pushes ‘virtual’ clinical trial concept
process. The aim is to expand the number of ‘virtual’ trials it runs, with patients interacting with investigators via mobile phones and telemedicine devices rather than attending investigation sites in person. ... It’s already running semi-virtual
-
PatientsLikeMe launches 'virtual trial' in ALS
to eliminate many of the frustrations patients say are inherent in traditional clinical trials. ... Attempts to pursue virtual trials within pharma have had mixed success to date, with Pfizer's pioneering efforts in managing study participation
-
inVentiv invests in virtual trials
Acquires equity stake in US-based Mytrus. Contract research organisation (CRO) inVentiv Health Clinical has acquired an equity stake in US-based 'virtual clinical trials' firm Mytrus. ... Mytrus, which was founded in 2009, has been developing
-
Pilot study combines patient-reported outcomes and medical records
As direct-to-patient observational studies grow in number and size, experience and insights from these designs can be considered for integration into interventional clinical trials,” the researchers wrote in the
More from news
Approximately 2 fully matching, plus 5 partially matching documents found.
Latest Intelligence
-
Bringing the trial to the patient
into specific trial methodologies like telehealth, remote/ virtual trials and direct-to-patient strategies. ... Extract from“An Actionable Approach to Decentralized Clinical Trials to Grow Enrollment and Retention” Melissa Hawking, Symphony Clinical
-
A new era of smart pharma
Transforming the approach to drug development. Recruitment of subjects plus their management and monitoring within trials is challenging and several organisations have tried to conduct ‘virtual trials’ with limited success. ... Clearly protocol
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. ... It’s technology like this that constantly reminds us how exploring new ways to communicate and leveraging virtual platforms can help us to better
-
Patients are ready for virtual clinical trials, are you?
While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid decentralised trials was slow. ... can take their trial out of the clinic and into a virtual setting.
-
Outsourcing in Clinical Trials 2020 Virtual Conference
We recently had the pleasure of sponsoring and attending the Outsourcing in Clinical Trials (OCT) virtual conference. ... Virtual trials or at least elements of virtual trials may come to the forefront faster than they otherwise would’ve done due to
-
Impetus Digital Fireside Chat with Craig Lipset from Clinical Innovation Partners
of e-patients, decentralized clinical trials, and other digital solutions.
-
Courageous Conversations ep.7: How to Quickly Pivot Clinical Studies to Virtual Platforms
Address:. Impetus Digital. WaterPark Place. 20 Bay Street, 11th Floor. Toronto. Ontario. M5J 2N8. Canada.
More from PMHub
Approximately 3 fully matching, plus 4 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
- New study identifies drugs that are safe to use in COVID-19 treatment
- Pfizer’s ALK inhibitor Lorbrena hits the mark in head-to-head lung cancer trial
- BMS eyes approval for second Opdivo combo in kidney cancer
- New medical communications agency BOLDSCIENCE launches
- Moderna inks R&D agreements with Vertex and Chiesi
- FDA hands BMS and bluebird bio a priority review for ide-cel
- Janssen’s EGFR-targeting treatment regimen shows early benefit in lung cancer
- Relief Therapeutics seeks US emergency approval for COVID-19 drug
- Could formulary intelligence be your brand differentiator?
- How COVID-19 is accelerating the threat of antimicrobial resistance
- Porterhouse Medical strengthens its senior management team
PMHub
90TEN
90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...
Latest intelligence
- Could formulary intelligence be your brand differentiator?
- Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
- How COVID-19 is accelerating the threat of antimicrobial resistance
- Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...
- Improve clinical trials through patient journey mapping
- Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...
Quick links
Infographics
